2024 ICD-10-CM Diagnosis Code T37.0X6S
Underdosing of sulfonamides, sequela
- ICD-10-CM Code:
- T37.0X6S
- ICD-10 Code for:
- Underdosing of sulfonamides, sequela
- Is Billable?
- Yes - Valid for Submission
- Chronic Condition Indicator: [1]
- Not chronic
- Code Navigator:
T37.0X6S is a billable diagnosis code used to specify a medical diagnosis of underdosing of sulfonamides, sequela. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
This code describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.
T37.0X6S is a sequela code, includes a 7th character and should be used for complications that arise as a direct result of a condition like underdosing of sulfonamides. According to ICD-10-CM Guidelines a "sequela" code should be used for chronic or residual conditions that are complications of an initial acute disease, illness or injury. The most common sequela is pain. Usually, two diagnosis codes are needed when reporting sequela. The first code describes the nature of the sequela while the second code describes the sequela or late effect.
Clinical Classification
Clinical Category is Poisoning/toxic effect/adverse effects/underdosing, sequela
- CCSR Category Code: INJ075
- Inpatient Default CCSR: X - Not applicable.
- Outpatient Default CCSR: X - Not applicable.
Clinical Information
Acedapsone
acetylated sulfone that is slowly metabolized to give long-term, low blood levels of dapsone. it has antimicrobial and antimalarial action, but is mainly used as a depot leprostatic agent.Sulfachlorpyridazine
a sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.Silver Sulfadiazine
antibacterial used topically in burn therapy.Sulfadiazine
one of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.Sulfadimethoxine
a sulfanilamide that is used as an anti-infective agent.Sulfadoxine
a long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.Sulfaguanidine
a sulfanilamide antimicrobial agent that is used to treat enteric infections.Sulfalene
long-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria.Sulfamerazine
a sulfanilamide that is used as an antibacterial agent.Sulfameter
long acting sulfonamide used in leprosy, urinary, and respiratory tract infections.Sulfamethazine
a sulfanilamide anti-infective agent. it has a spectrum of antimicrobial action similar to other sulfonamides.Sulfamethizole
a sulfathiazole antibacterial agent.Sulfamethoxazole
a bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. its broad spectrum of activity has been limited by the development of resistance. (from martindale, the extra pharmacopoeia, 30th ed, p208)Trimethoprim, Sulfamethoxazole Drug Combination
a drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. it is effective in the treatment of many infections, including pneumocystis pneumonia in aids.Sulfamethoxypyridazine
a sulfanilamide antibacterial agent.Sulfamonomethoxine
long acting sulfonamide antibacterial agent.Sulfamoxole
a sulfanilamide antibacterial agent.Sulfanilamide
a short-acting sulfonamide used as an anti-infective agent. it has lower anti-bacterial activity than sulfamethoxazole.Sulfanilamides
compounds based on 4-aminobenzenesulfonamide. the '-anil-' part of the name refers to aniline.Sulfaphenazole
a sulfonilamide anti-infective agent.Sulfapyridine
antibacterial, potentially toxic, used to treat certain skin diseases.Sulfasalazine
a drug that is used in the management of inflammatory bowel diseases. its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see mesalamine) released in the colon. (from martindale, the extra pharmacopoeia, 30th ed, p907)Sulfathiazole
a sulfathiazole compound that is used as a short-acting anti-infective agent. it is no longer commonly used systemically due to its toxicity, but may still be applied topically in combination with other drugs for the treatment of vaginal and skin infections, and is still used in veterinary medicine.Sulfathiazoles
sulfanilamides consisting of a 4-aminobenzenesulfonamido group at the 2-position of 1,3-thiazole. they are often used as anti-infective agents.Sulfisomidine
a sulfanilamide antibacterial agent.Sulfisoxazole
a short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
Coding Guidelines
Underdosing refers to taking less of a medication than is prescribed by a provider or a manufacturer's instruction. Codes for underdosing should never be assigned as principal or first-listed codes. If a patient has a relapse or exacerbation of the medical condition for which the drug is prescribed because of the reduction in dose, then the medical condition itself should be coded.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics (T37). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10-CM Code Edits are applicable to this code:
- Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.
Present on Admission (POA)
T37.0X6S is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
POA Indicator | Reason for Code | CMS will pay the CC/MCC DRG? |
---|---|---|
Y | Diagnosis was present at time of inpatient admission. | YES |
N | Diagnosis was not present at time of inpatient admission. | NO |
U | Documentation insufficient to determine if the condition was present at the time of inpatient admission. | NO |
W | Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission. | YES |
1 | Unreported/Not used - Exempt from POA reporting. | NO |
Table of Drugs and Chemicals
The parent code T37.0X6 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Patient Education
Medication Errors
Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:
- Knowing your medicines. When you get a prescription, ask the name of the medicine and check to make sure that the pharmacy gave you the right medicine. Make sure that you understand how often you should take the medicine and how long you should take it.
- Keeping a list of medicines.
- Write down all of the medicines that you are taking, including the names of your medicines, how much you take, and when you take them. Make sure to include any over-the-counter medicines, vitamins, supplements, and herbs that you take.
- List the medicines that you are allergic to or that have caused you problems in the past.
- Take this list with you every time you see a health care provider.
- Reading medicine labels and following the directions. Don't just rely on your memory - read the medication label every time. Be especially careful when giving medicines to children.
- Asking questions. If you don't know the answers to these questions, ask your health care provider or pharmacist:
- Why am I taking this medicine?
- What are the common side effects?
- What should I do if I have side effects?
- When should I stop this medicine?
- Can I take this medicine with the other medicines and supplements on my list?
- Do I need to avoid certain foods or alcohol while taking this medicine?
Food and Drug Administration
[Learn More in MedlinePlus]
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.